Mitoxantrone,  a multiple sclerosis (MS)  drug that is already associated with a higher risk for leukemia and heart damage, may also raise a person’s risk of colorectal cancer, researchers at the University of Würzburg, in Germany, reported. If confirmed in larger studies, the findings indicate that colonoscopies should be conducted on MS patients after…
mitoxantrone
New research from Italy and Spain demonstrated that intense immunosuppression followed by autologous hematopoietic stem cell transplantation (AHSCT) was better than the medication mitoxantrone in treating severe cases of multiple sclerosis. The study appeared in the February 11, 2015, online issue of Neurology.  MS is characterized by an immune system attack on the…
Recommended Posts
- MS treatment during pregnancy found safe for babies’ brain growth
- A springtime downpour brings back memories of my biggest supporter
- New blood test may help track MS disease between relapses
- Nearly 60% higher risk of MS seen for people with diabetes in new study
- MS caregiving is an emotional roller coaster I didn’t anticipate